$RXO
RXO, Inc.

2023 Q2 Form 10-Q Financial Statement

#000192956123000057 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $963.0M $1.010B $1.312B
YoY Change -21.45% -23.02% 23.19%
Cost Of Revenue $782.0M $820.0M $1.076B
YoY Change -18.54% -23.79% 25.26%
Gross Profit $181.0M $190.0M $236.0M
YoY Change -31.95% -19.49% 14.56%
Gross Profit Margin 18.8% 18.81% 17.99%
Selling, General & Admin $144.0M $153.0M $161.0M
YoY Change -13.25% -4.97% 21.05%
% of Gross Profit 79.56% 80.53% 68.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.00M $18.00M $21.00M
YoY Change -14.29% -14.29% 5.0%
% of Gross Profit 9.94% 9.47% 8.9%
Operating Expenses $162.0M $153.0M $182.0M
YoY Change -13.37% -15.93% 18.95%
Operating Profit $19.00M $5.000M $54.00M
YoY Change -75.95% -90.74% 1.89%
Interest Expense -$8.000M -$8.000M $0.00
YoY Change
% of Operating Profit -42.11% -160.0% 0.0%
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income $6.000M -$3.000M $51.00M
YoY Change -89.83% -105.88% 2.0%
Income Tax $3.000M -$3.000M $12.00M
% Of Pretax Income 50.0% 23.53%
Net Earnings $3.000M $0.00 $39.00M
YoY Change -93.18% -100.0% -2.5%
Net Earnings / Revenue 0.31% 0.0% 2.97%
Basic Earnings Per Share $0.03 $0.00 $0.34
Diluted Earnings Per Share $0.03 $0.00 $0.34
COMMON SHARES
Basic Shares Outstanding 116.9M shares 116.6M shares 115.2M shares
Diluted Shares Outstanding 119.5M shares 119.4M shares 115.2M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $124.0M $121.0M $46.00M
YoY Change -41.51% 163.04%
Cash & Equivalents $124.0M $121.0M $46.00M
Short-Term Investments
Other Short-Term Assets $49.00M $46.00M $42.00M
YoY Change 53.13% 9.52%
Inventory
Prepaid Expenses
Receivables $743.0M $862.0M $1.218B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $916.0M $1.029B $1.306B
YoY Change -32.2% -21.21%
LONG-TERM ASSETS
Property, Plant & Equipment $280.0M $269.0M $248.0M
YoY Change -1.41% 8.47%
Goodwill $630.0M $630.0M
YoY Change
Intangibles $73.00M $76.00M
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.00M $14.00M $17.00M
YoY Change -23.53% -17.65%
Total Long-Term Assets $996.0M $989.0M $990.0M
YoY Change -2.45% -0.1%
TOTAL ASSETS
Total Short-Term Assets $916.0M $1.029B $1.306B
Total Long-Term Assets $996.0M $989.0M $990.0M
Total Assets $1.912B $2.018B $2.296B
YoY Change -19.39% -12.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $432.0M $496.0M $734.0M
YoY Change -29.76% -32.43%
Accrued Expenses $258.0M $265.0M $324.0M
YoY Change -23.67% -18.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.000M $4.000M
YoY Change
Total Short-Term Liabilities $699.0M $820.0M $1.063B
YoY Change -26.96% -22.86%
LONG-TERM LIABILITIES
Long-Term Debt $451.0M $451.0M $0.00
YoY Change
Other Long-Term Liabilities $156.0M $37.00M $138.0M
YoY Change -5.45% -73.19%
Total Long-Term Liabilities $607.0M $613.0M $138.0M
YoY Change 267.88% 344.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $699.0M $820.0M $1.063B
Total Long-Term Liabilities $607.0M $613.0M $138.0M
Total Liabilities $1.323B $1.433B $1.253B
YoY Change 12.79% 14.37%
SHAREHOLDERS EQUITY
Retained Earnings $5.000M $2.000M
YoY Change
Common Stock $1.000M $1.000M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $589.0M $585.0M $1.043B
YoY Change
Total Liabilities & Shareholders Equity $1.912B $2.018B $2.296B
YoY Change -19.39% -12.11%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $3.000M $0.00 $39.00M
YoY Change -93.18% -100.0% -2.5%
Depreciation, Depletion And Amortization $18.00M $18.00M $21.00M
YoY Change -14.29% -14.29% 5.0%
Cash From Operating Activities $24.00M $42.00M $103.0M
YoY Change -67.57% -59.22% 758.33%
INVESTING ACTIVITIES
Capital Expenditures $16.00M $12.00M $12.00M
YoY Change 33.33% 0.0% 33.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$16.00M -$12.00M -$12.00M
YoY Change 33.33% 0.0% 33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.000M -$8.000M -74.00M
YoY Change -104.81% -89.19% -628.57%
NET CHANGE
Cash From Operating Activities 24.00M $42.00M 103.0M
Cash From Investing Activities -16.00M -$12.00M -12.00M
Cash From Financing Activities -5.000M -$8.000M -74.00M
Net Change In Cash 3.000M $23.00M 17.00M
YoY Change -98.19% 35.29% 0.0%
FREE CASH FLOW
Cash From Operating Activities $24.00M $42.00M $103.0M
Capital Expenditures $16.00M $12.00M $12.00M
Free Cash Flow $8.000M $30.00M $91.00M
YoY Change -87.1% -67.03% 2933.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001929561
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41514
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
RXO, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-2183384
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11215 North Community House Road
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28277
CY2023Q1 dei City Area Code
CityAreaCode
980
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
308-6058
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
RXO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
116922893 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
862000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
900000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
46000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
31000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1029000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1029000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
255000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
241000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
117000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
119000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
159000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
630000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
630000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
110000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
106000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000000 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
989000000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1002000000 usd
CY2023Q1 us-gaap Assets
Assets
2018000000 usd
CY2022Q4 us-gaap Assets
Assets
2031000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
496000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
501000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
265000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
256000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
820000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
823000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
613000000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
621000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116853000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
116853000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
116400000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116400000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
586000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
588000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
587000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2018000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2031000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1312000000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
759000000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1021000000 usd
CY2023Q1 rxo Direct Operating Expense Excluding Depreciation Depletion And Amortization
DirectOperatingExpenseExcludingDepreciationDepletionAndAmortization
61000000 usd
CY2022Q1 rxo Direct Operating Expense Excluding Depreciation Depletion And Amortization
DirectOperatingExpenseExcludingDepreciationDepletionAndAmortization
55000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21000000 usd
CY2023Q1 rxo Transaction And Integration Costs
TransactionAndIntegrationCosts
6000000 usd
CY2022Q1 rxo Transaction And Integration Costs
TransactionAndIntegrationCosts
3000000 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
8000000 usd
CY2022Q1 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
51000000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8000000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119369000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
210000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1000000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
31000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023Q1 rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
0 usd
CY2022Q1 rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
74000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-74000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10000000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
23000000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
153000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.97
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
587000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5000000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
453000 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1070000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
39000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2000000 usd
CY2022Q1 rxo Net Transfers To Parent
NetTransfersToParent
70000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1043000000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportingsegment
CY2022Q4 rxo Stockholders Equity Note Spinoff Transaction Percent Of Shares Outstanding Distributed
StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed
1
CY2022Q4 rxo Shares Of Companys Common Stock
SharesOfCompanysCommonStock
1 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1312000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1312000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
3000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
8000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3000000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
8000000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
464000000 usd
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
455000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
464000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
455000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q1 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
460000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2022Q4 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
460000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
39000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2769000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119369000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000 shares

Files In Submission

Name View Source Status
0001929561-23-000057-index-headers.html Edgar Link pending
0001929561-23-000057-index.html Edgar Link pending
0001929561-23-000057.txt Edgar Link pending
0001929561-23-000057-xbrl.zip Edgar Link pending
a2023rxorsuagreementex-1017.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
rxo-20230331.htm Edgar Link pending
rxo-20230331.xsd Edgar Link pending
rxo-20230331_g1.jpg Edgar Link pending
rxo2023q110-qexx311.htm Edgar Link pending
rxo2023q110-qexx312.htm Edgar Link pending
rxo2023q110-qexx321.htm Edgar Link pending
rxo2023q110-qexx322.htm Edgar Link pending
Show.js Edgar Link pending
rxo-20230331_cal.xml Edgar Link unprocessable
rxo-20230331_def.xml Edgar Link unprocessable
rxo-20230331_lab.xml Edgar Link unprocessable
rxo-20230331_pre.xml Edgar Link unprocessable
rxo-20230331_htm.xml Edgar Link completed